First Light Asset Management LLC Boosts Stock Holdings in Health Catalyst, Inc. $HCAT

Key Points

• First Light Asset Management LLC has increased its holdings in Health Catalyst, Inc. by 99.1%, now owning approximately 10,436,807 shares, making it the firm's 6th largest holding.
• Health Catalyst, Inc. has recently seen multiple analysts downgrade its ratings, with price targets significantly lowered; for instance, Citigroup cut its price target from $6.50 to $3.50.
• The current market capitalization of Health Catalyst is approximately $238.55 million, with its shares trading down 7.1% to $3.39.

First Light Asset Management LLC boosted its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 99.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,436,807 shares of the company's stock after purchasing an additional 5,195,686 shares during the quarter. Health Catalyst comprises about 5.4% of First Light Asset Management LLC's portfolio, making the stock its 6th biggest holding. First Light Asset Management LLC owned approximately 14.86% of Health Catalyst worth $47,279,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in HCAT. Nepsis Inc. boosted its stake in Health Catalyst by 2,072.1% in the 1st quarter. Nepsis Inc. now owns 2,090,812 shares of the company's stock valued at $9,471,000 after purchasing an additional 1,994,555 shares during the period. Whetstone Capital Advisors LLC bought a new stake in shares of Health Catalyst during the 1st quarter valued at $7,724,000. Alyeska Investment Group L.P. lifted its position in shares of Health Catalyst by 74.4% during the 4th quarter. Alyeska Investment Group L.P. now owns 2,019,380 shares of the company's stock valued at $14,277,000 after acquiring an additional 861,150 shares during the period. Nuveen LLC bought a new stake in shares of Health Catalyst during the 1st quarter valued at $2,674,000. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in shares of Health Catalyst by 172.6% during the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 694,361 shares of the company's stock valued at $3,145,000 after acquiring an additional 439,599 shares during the period. 85.00% of the stock is currently owned by institutional investors.

Health Catalyst Price Performance

HCAT traded up $0.08 on Friday, reaching $3.38. The stock had a trading volume of 789,220 shares, compared to its average volume of 1,129,022. Health Catalyst, Inc. has a fifty-two week low of $2.52 and a fifty-two week high of $9.24. The firm has a 50-day moving average of $3.59 and a 200-day moving average of $3.94. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $237.85 million, a price-to-earnings ratio of -2.24 and a beta of 1.53.

Wall Street Analyst Weigh In

HCAT has been the subject of several analyst reports. Cantor Fitzgerald restated a "neutral" rating and issued a $4.00 target price (down from $9.00) on shares of Health Catalyst in a research report on Friday, August 8th. Stifel Nicolaus dropped their target price on shares of Health Catalyst from $5.50 to $4.50 and set a "hold" rating for the company in a research report on Friday, August 8th. Summit Redstone set a $5.00 target price on shares of Health Catalyst in a research report on Friday, August 29th. Wells Fargo & Company lowered their price target on Health Catalyst from $10.00 to $6.00 and set an "overweight" rating for the company in a report on Monday, August 11th. Finally, Citigroup cut Health Catalyst from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $6.50 to $3.50 in a report on Friday, August 8th. Three equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $4.73.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.